Last deal

$56M

Amount

Series A

Stage

23.02.2022

Date

1

all rounds

$56M

Total amount

General

About Company
Spatial Genomics is a biology and life science technology company.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2016

Number of employees

Last funding type

Series A

IPO status

Private

Description

They are developing an integrated platform of instrumentation, reagents, and software to enable high multiplexity of multi-omic biological analysis. Their technology allows for the identification of many RNA transcripts directly in single cells, preserving their spatial context. This helps map gene expression and generate the human cell atlas, advancing fundamental biology, precision medicine, drug discovery, and biomarker discovery. Spatial Genomics aims to become a standard research tool used worldwide.
Contacts

Phone number

Social url